| Trial ID: | L5154 |
| Source ID: | NCT00577590
|
| Associated Drug: |
Metformin
|
| Title: |
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
|
| Acronym: |
T2DM
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00577590/results
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: Metformin|DRUG: Rosiglitazone|DRUG: Lovaza
|
| Outcome Measures: |
Primary: Percent Change in Plasma Triglycerides, Baseline and 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Washington University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
78
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-10
|
| Completion Date: |
2012-09
|
| Results First Posted: |
2018-08-31
|
| Last Update Posted: |
2018-08-31
|
| Locations: |
Washington University in St. Louis, Saint Louis, Missouri, 63110, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00577590
|
